Publicaciones (178) Publicaciones de MANUEL MENENDEZ GONZALEZ

2025

  1. Assessing the association between common functional Nuclear Factor Kappa-b gene polymorphisms (NFKB1, NFKBIZ, NFKBIA) and Alzheimer´s disease

    Behavioural Brain Research, Vol. 476

2024

  1. An Insertion Within SIRPβ1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response

    Journal of Alzheimer's Disease, Vol. 98, Núm. 2, pp. 601-618

  2. Analysis of the Influence of Depression on the Occupational Performance of People Diagnosed with Multiple Sclerosis and Its Impact on Caregiver Burden

    Depression and Anxiety, Vol. 2024

  3. Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced Dyskinesia

    Movement Disorders, Vol. 39, Núm. 10, pp. 1773-1783

  4. Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia

    American Journal of Human Genetics, Vol. 111, Núm. 7, pp. 1316-1329

  5. Huntingtin CAG repeats in neuropathologically confirmed tauopathies: Novel insights

    Brain Pathology, Vol. 34, Núm. 4

  6. Influence of manipulative skills on quality of life and activities of daily living in multiple sclerosis

    Revista de Neurologia, Vol. 78, Núm. 8, pp. 213-218

  7. Intrathecal Immunoselective Nanopheresis for Alzheimer’s Disease: What and How? Why and When?

    International Journal of Molecular Sciences, Vol. 25, Núm. 19

  8. Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study

    Movement Disorders Clinical Practice, Vol. 11, Núm. 7, pp. 830-849

  9. NFKB1 variants were associated with the risk of Parkinson´s disease in male

    Journal of Neural Transmission, Vol. 131, Núm. 7, pp. 773-779

  10. Pharmacotherapy for behavioural manifestations in frontotemporal dementia: An expert consensus from the European Reference Network for Rare Neurological Diseases (ERN-RND)

    European Journal of Neurology, Vol. 31, Núm. 12

  11. The Potential of Liquorpheresis to Treat Leptomeningeal Disease

    World Neurosurgery, Vol. 187, pp. 93-98

2023

  1. A Nanostructured Protein Filtration Device for Possible Use in the Treatment of Alzheimer’s Disease—Concept and Feasibility after In Vivo Tests

    Bioengineering, Vol. 10, Núm. 11

  2. Changes in Principal Caregiver Mood Affects the Mood of the Parkinson's Disease Patient: The Vicious Cycle of Illness

    Journal of Parkinson's disease, Vol. 13, Núm. 2, pp. 219-231

  3. Cognitive impairment and dementia in young onset Parkinson’s disease

    Journal of Neurology, Vol. 270, Núm. 12, pp. 5793-5812

  4. Cumulative Genetic Score and C9orf72 Repeat Status Independently Contribute to Amyotrophic Lateral Sclerosis Risk in 2 Case-Control Studies

    Neurology: Genetics, Vol. 9, Núm. 4

  5. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort

    Movement Disorders, Vol. 38, Núm. 2, pp. 286-303

  6. Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))

    Nature communications

  7. Falls Predict Acute Hospitalization in Parkinson's Disease

    Journal of Parkinson's disease, Vol. 13, Núm. 1, pp. 105-124

  8. Intrathecal Pseudodelivery of Drugs in the Therapy of Neurodegenerative Diseases: Rationale, Basis and Potential Applications

    Pharmaceutics, Vol. 15, Núm. 3